Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
Clinical trial NCT06932471 · RECRUITING
Trial details
- NCT number
- NCT06932471
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2025-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.